Regulation of RIG-I Activation by K63-Linked Polyubiquitination

Frontiers in Immunology

Volumn 8, Issue JAN, 2018, Pages

  Okamoto, Masaaki ^a   Kouwaki, Takahisa ^a   Fukushima, Yoshimi ^a   Oshiumi, Hiroyuki ^a,b  

^a KUMAMOTO UNIVERSITY   (Japan)

^b JAPAN SCIENCE AND TECHNOLOGY AGENCY   (Japan)

Author keywords

Innate immunity; RIG I; Signaling pathway; Ubiquitin; Virus

Indexed keywords

RETINOIC ACID INDUCIBLE PROTEIN I; UBIQUITIN PROTEIN LIGASE;

AMINO TERMINAL SEQUENCE; GENE EXPRESSION; HEPATITIS C VIRUS; IMMUNOPRECIPITATION; INFLUENZA A VIRUS; INNATE IMMUNITY; KNOCKOUT GENE; MASS SPECTROMETRY; MOLECULAR RECOGNITION; NONHUMAN; PROTEIN DOMAIN; PROTEIN EXPRESSION; SHORT SURVEY; SIGNAL TRANSDUCTION; UBIQUITINATION; VIRUS INFECTION;

EID: 85040122916     PISSN: None     EISSN: 16643224     Source Type: Journal    
DOI: 10.3389/fimmu.2017.01942     Document Type: Short Survey

References (50)

1. Loo YM, Gale M Jr. Immune signaling by RIG-I-like receptors. Immunity (2011) 34:680-92. doi:10.1016/j.immuni.2011.05.003
2. Kawai T, Akira S. Toll-like receptors and their crosstalk with other innate receptors in infection and immunity. Immunity (2011) 34:637-50. doi:10.1016/j.immuni.2011.05.006
3. Goubau D, Schlee M, Deddouche S, Pruijssers AJ, Zillinger T, Goldeck M, et al. Antiviral immunity via RIG-I-mediated recognition of RNA bearing 5'-diphosphates. Nature (2014) 514:372-5. doi:10.1038/nature13590
4. Hornung V, Ellegast J, Kim S, Brzozka K, Jung A, Kato H, et al. 5'-Triphosphate RNA is the ligand for RIG-I. Science (2006) 314:994-7. doi:10.1126/science.1132505
5. Yoneyama M, Kikuchi M, Natsukawa T, Shinobu N, Imaizumi T, Miyagishi M, et al. The RNA helicase RIG-I has an essential function in double-stranded RNA-induced innate antiviral responses. Nat Immunol (2004) 5:730-7. doi:10.1038/ni1087
6. Kato H, Takeuchi O, Mikamo-Satoh E, Hirai R, Kawai T, Matsushita K, et al. Length-dependent recognition of double-stranded ribonucleic acids by retinoic acid-inducible gene-I and melanoma differentiation-associated gene 5. J Exp Med (2008) 205:1601-10. doi:10.1084/jem.20080091
7. Loo YM, Fornek J, Crochet N, Bajwa G, Perwitasari O, Martinez-Sobrido L, et al. Distinct RIG-I and MDA5 signaling by RNA viruses in innate immunity. J Virol (2008) 82:335-45. doi:10.1128/JVI.01080-07
8. Kato H, Takeuchi O, Sato S, Yoneyama M, Yamamoto M, Matsui K, et al. Differential roles of MDA5 and RIG-I helicases in the recognition of RNA viruses. Nature (2006) 441:101-5. doi:10.1038/nature04734
9. Seth RB, Sun L, Ea CK, Chen ZJ. Identification and characterization of MAVS, a mitochondrial antiviral signaling protein that activates NF-kappaB and IRF 3. Cell (2005) 122:669-82. doi:10.1016/j.cell.2005.08.012
10. Kawai T, Takahashi K, Sato S, Coban C, Kumar H, Kato H, et al. IPS-1, an adaptor triggering RIG-I- and Mda5-mediated type I interferon induction. Nat Immunol (2005) 6:981-8. doi:10.1038/ni1243
11. Xu LG, Wang YY, Han KJ, Li LY, Zhai Z, Shu HB. VISA is an adapter protein required for virus-triggered IFN-beta signaling. Mol Cell (2005) 19:727-40. doi:10.1016/j.molcel.2005.08.014
12. Meylan E, Curran J, Hofmann K, Moradpour D, Binder M, Bartenschlager R, et al. Cardif is an adaptor protein in the RIG-I antiviral pathway and is targeted by hepatitis C virus. Nature (2005) 437:1167-72. doi:10.1038/nature04193
13. Hou F, Sun L, Zheng H, Skaug B, Jiang QX, Chen ZJ. MAVS forms functional prion-like aggregates to activate and propagate antiviral innate immune response. Cell (2011) 146:448-61. doi:10.1016/j.cell.2011.06.041
14. Saito T, Hirai R, Loo YM, Owen D, Johnson CL, Sinha SC, et al. Regulation of innate antiviral defenses through a shared repressor domain in RIG-I and LGP2. Proc Natl Acad Sci U S A (2007) 104:582-7. doi:10.1073/pnas.0606699104
15. Yoneyama M, Kikuchi M, Matsumoto K, Imaizumi T, Miyagishi M, Taira K, et al. Shared and unique functions of the DExD/H-box helicases RIG-I, MDA5, and LGP2 in antiviral innate immunity. J Immunol (2005) 175:2851-8. doi:10.4049/jimmunol.175.5.2851
16. Takahasi K, Yoneyama M, Nishihori T, Hirai R, Kumeta H, Narita R, et al. Nonself RNA-sensing mechanism of RIG-I helicase and activation of antiviral immune responses. Mol Cell (2008) 29:428-40. doi:10.1016/j.molcel.2007.11.028
17. Cui S, Eisenacher K, Kirchhofer A, Brzozka K, Lammens A, Lammens K, et al. The C-terminal regulatory domain is the RNA 5'-triphosphate sensor of RIG-I. Mol Cell (2008) 29:169-79. doi:10.1016/j.molcel.2007.10.032
18. Kageyama M, Takahasi K, Narita R, Hirai R, Yoneyama M, Kato H, et al. 55 Amino acid linker between helicase and carboxyl terminal domains of RIG-I functions as a critical repression domain and determines inter-domain conformation. Biochem Biophys Res Commun (2011) 415:75-81. doi:10.1016/j.bbrc.2011.10.015
19. Peisley A, Wu B, Yao H, Walz T, Hur S. RIG-I forms signaling-competent filaments in an ATP-dependent, ubiquitin-independent manner. Mol Cell (2013) 51:573-83. doi:10.1016/j.molcel.2013.07.024
20. Wu B, Peisley A, Richards C, Yao H, Zeng X, Lin C, et al. Structural basis for dsRNA recognition, filament formation, and antiviral signal activation by MDA5. Cell (2013) 152:276-89. doi:10.1016/j.cell.2012.11.048
21. Peisley A, Wu B, Xu H, Chen ZJ, Hur S. Structural basis for ubiquitin-mediated antiviral signal activation by RIG-I. Nature (2014) 509:110-4. doi:10.1038/nature13140
22. Gack MU, Shin YC, Joo CH, Urano T, Liang C, Sun L, et al. TRIM25 RING-finger E3 ubiquitin ligase is essential for RIG-I-mediated antiviral activity. Nature (2007) 446:916-20. doi:10.1038/nature05732
23. Zeng W, Sun L, Jiang X, Chen X, Hou F, Adhikari A, et al. Reconstitution of the RIG-I pathway reveals a signaling role of unanchored polyubiquitin chains in innate immunity. Cell (2010) 141:315-30. doi:10.1016/j.cell.2010.03.029
24. Oshiumi H, Miyashita M, Matsumoto M, Seya T. A distinct role of Riplet-mediated K63-linked polyubiquitination of the RIG-I repressor domain in human antiviral innate immune responses. PLoS Pathog (2013) 9:e1003533. doi:10.1371/journal.ppat.1003533
25. Arnaud N, Dabo S, Akazawa D, Fukasawa M, Shinkai-Ouchi F, Hugon J, et al. Hepatitis C virus reveals a novel early control in acute immune response. PLoS Pathog (2011) 7:e1002289. doi:10.1371/journal.ppat.1002289
26. Chiang C, Gack MU. Post-translational control of intracellular pathogen sensing pathways. Trends Immunol (2017) 38:39-52. doi:10.1016/j.it.2016.10.008
27. Chan YK, Gack MU. Viral evasion of intracellular DNA and RNA sensing. Nat Rev Microbiol (2016) 14:360-73. doi:10.1038/nrmicro.2016.45
28. Oshiumi H, Matsumoto M, Hatakeyama S, Seya T. Riplet/RNF135, a RING finger protein, ubiquitinates RIG-I to promote interferon-beta induction during the early phase of viral infection. J Biol Chem (2009) 284:807-17. doi:10.1074/jbc.M804259200
29. Kuniyoshi K, Takeuchi O, Pandey S, Satoh T, Iwasaki H, Akira S, et al. Pivotal role of RNA-binding E3 ubiquitin ligase MEX3C in RIG-I-mediated antiviral innate immunity. Proc Natl Acad Sci U S A (2014) 111:5646-51. doi:10.1073/pnas.1401674111
30. Yan J, Li Q, Mao AP, Hu MM, Shu HB. TRIM4 modulates type I interferon induction and cellular antiviral response by targeting RIG-I for K63-linked ubiquitination. J Mol Cell Biol (2014) 6:154-63. doi:10.1093/jmcb/mju005
31. Sanchez JG, Chiang JJ, Sparrer KMJ, Alam SL, Chi M, Roganowicz MD, et al. Mechanism of TRIM25 catalytic activation in the antiviral RIG-I pathway. Cell Rep (2016) 16:1315-25. doi:10.1016/j.celrep.2016.06.070
32. Oshiumi H, Matsumoto M, Seya T. Ubiquitin-mediated modulation of the cytoplasmic viral RNA sensor RIG-I. J Biochem (2012) 151:5-11. doi:10.1093/jb/mvr111
33. Shigemoto T, Kageyama M, Hirai R, Zheng J, Yoneyama M, Fujita T. Identification of loss of function mutations in human genes encoding RIG-I and MDA5: implications for resistance to type I diabetes. J Biol Chem (2009) 284:13348-54. doi:10.1074/jbc.M809449200
34. Shi Y, Yuan B, Zhu W, Zhang R, Li L, Hao X, et al. Ube2D3 and Ube2N are essential for RIG-I-mediated MAVS aggregation in antiviral innate immunity. Nat Commun (2017) 8:15138. doi:10.1038/ncomms15138
35. Oshiumi H, Miyashita M, Inoue N, Okabe M, Matsumoto M, Seya T. The ubiquitin ligase Riplet is essential for RIG-I-dependent innate immune responses to RNA virus infection. Cell Host Microbe (2010) 8:496-509. doi:10.1016/j.chom.2010.11.008
36. Luo D, Kohlway A, Vela A, Pyle AM. Visualizing the determinants of viral RNA recognition by innate immune sensor RIG-I. Structure (2012) 20:1983-8. doi:10.1016/j.str.2012.08.029
37. Gao D, Yang YK, Wang RP, Zhou X, Diao FC, Li MD, et al. REUL is a novel E3 ubiquitin ligase and stimulator of retinoic-acid-inducible gene-I. PLoS One (2009) 4:e5760. doi:10.1371/journal.pone.0005760
38. Diebold SS, Montoya M, Unger H, Alexopoulou L, Roy P, Haswell LE, et al. Viral infection switches non-plasmacytoid dendritic cells into high interferon producers. Nature (2003) 424:324-8. doi:10.1038/nature01783
39. Gack MU, Albrecht RA, Urano T, Inn KS, Huang IC, Carnero E, et al. Influenza A virus NS1 targets the ubiquitin ligase TRIM25 to evade recognition by the host viral RNA sensor RIG-I. Cell Host Microbe (2009) 5:439-49. doi:10.1016/j.chom.2009.04.006
40. Rajsbaum R, Albrecht RA, Wang MK, Maharaj NP, Versteeg GA, Nistal-Villan E, et al. Species-specific inhibition of RIG-I ubiquitination and IFN induction by the influenza A virus NS1 protein. PLoS Pathog (2012) 8:e1003059. doi:10.1371/journal.ppat.1003059
41. Hu Y, Li W, Gao T, Cui Y, Jin Y, Li P, et al. The severe acute respiratory syndrome coronavirus nucleocapsid inhibits type I interferon production by interfering with TRIM25-mediated RIG-I ubiquitination. J Virol (2017) 91:e02143-16. doi:10.1128/JVI.02143-16 CrossRef Full Text | Google Scholar
42. Urano T, Saito T, Tsukui T, Fujita M, Hosoi T, Muramatsu M, et al. Efp targets 14-3-3 sigma for proteolysis and promotes breast tumour growth. Nature (2002) 417:871-5. doi:10.1038/nature00826
43. Douglas J, Cilliers D, Coleman K, Tatton-Brown K, Barker K, Bernhard B, et al. Mutations in RNF135, a gene within the NF1 microdeletion region, cause phenotypic abnormalities including overgrowth. Nat Genet (2007) 39:963-5. doi:10.1038/ng2083
44. Tastet J, Decalonne L, Marouillat S, Malvy J, Thepault RA, Toutain A, et al. Mutation screening of the ubiquitin ligase gene RNF135 in French patients with autism. Psychiatr Genet (2015) 25:263-7. doi:10.1097/YPG.0000000000000100
45. Liu Y, Wang F, Liu Y, Yao Y, Lv X, Dong B, et al. RNF135, RING finger protein, promotes the proliferation of human glioblastoma cells in vivo and in vitro via the ERK pathway. Sci Rep (2016) 6:20642. doi:10.1038/srep20642
46. Jin J, Zhao L, Li Z. The E3 ubiquitin ligase RNF135 regulates the tumorigenesis activity of tongue cancer SCC25 cells. Cancer Med (2016) 5:3140-6. doi:10.1002/cam4.832
47. Venkataraman T, Valdes M, Elsby R, Kakuta S, Caceres G, Saijo S, et al. Loss of DExD/H box RNA helicase LGP2 manifests disparate antiviral responses. J Immunol (2007) 178:6444-55. doi:10.4049/jimmunol.178.10.6444
48. Satoh T, Kato H, Kumagai Y, Yoneyama M, Sato S, Matsushita K, et al. LGP2 is a positive regulator of RIG-I- and MDA5-mediated antiviral responses. Proc Natl Acad Sci U S A (2010) 107:1512-7. doi:10.1073/pnas.0912986107
49. Bruns AM, Leser GP, Lamb RA, Horvath CM. The innate immune sensor LGP2 activates antiviral signaling by regulating MDA5-RNA interaction and filament assembly. Mol Cell (2014) 55:771-81. doi:10.1016/j.molcel.2014.07.003
50. Suthar MS, Ramos HJ, Brassil MM, Netland J, Chappell CP, Blahnik G, et al. The RIG-I-like receptor LGP2 controls CD8(+) T cell survival and fitness. Immunity (2012) 37:235-48. doi:10.1016/j.immuni.2012.07.004